The short version
Only one company currently supplies this market — there is no backup if it stumbles. It is in shortage right now — FDA lists the reason as “other”.
Market view
meperidine hydrochloride · Injection, Solution
4 marketed package NDCs · 1 active manufacturer
Most dispensed: 50 mg/5mL · Solution · #500 mL/bottle
What changed in the last 90 days
Every detected change for meperidine hydrochloride, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Meperidine HydrochlorideAug 19, 2026Price downNADAC $0.15618 → $0.15579 per unit (-0.25%)
- DemerolJul 29, 2026Mfr exitedHospira, Inc. · meperidine hydrochloride
- Meperidine HydrochlorideJul 22, 2026Price downNADAC $0.1568 → $0.15618 per unit (-0.4%)
Same drug class
Other molecules FDA puts in Opioid Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- morphine· in shortage
- fentanyl· in shortage
- remifentanil hydrochloride· in shortage
- sufentanil citrate· in shortage
- fentanyl citrate· in shortage
- hydromorphone hydrochloride· in shortage
- morphine sulfate· in shortage
- acetaminophen, caffeine, dihydrocodeine bitartrate· 1 maker
- butalbital, aspirin, cafeine, and codeine phosphate· 1 maker
- codeine phosphate and chlorpheniramine maleate· 1 maker
- codeine phosphate, dexbrompheniramine maleate· 1 maker
- fentanyl transdermal· 1 maker
Common questions
- Is Meperidine hydrochloride in shortage right now?
- Yes. FDA currently lists Meperidine hydrochloride in shortage, with the reason given as "other". This page is rebuilt every morning from FDA's shortage database.
- Who makes Meperidine hydrochloride?
- 8 companies have marketed Meperidine hydrochloride in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Meperidine hydrochloride cost?
- The typical pharmacy pays about $0.1558 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
Shortage reports for this molecule
- In shortage now — Demerol, Injection, 25 mg/1 mL (NDC 0409-1176-30)May 30, 2025
- In shortage now — Demerol, Injection, 50 mg/1 mL (NDC 0409-1178-30)May 30, 2025
- In shortage now — Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30)May 30, 2025
- In shortage now — Demerol, Injection, 75 mg/1 mL (NDC 0409-1179-30)May 30, 2025
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.